Product Images Sumatriptan Succinate

This is a description of a medication called Sumatriptan Succinate Tablets, with a strength of 100mg. The tablets come in a blister pack of 9 (1 X 9) unit-of-use tablets, manufactured by Sun Pharmaceutical Industries. The tablets should be swallowed whole with water and should not be removed from the blister pack until immediately prior to use. Dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C (68°to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). Instructions are provided for tearing the blister pack and removing the tablet with dry hands to put it in the mouth.*

This is a description of Sumatriptan Succinate Tablets, with NDC 62756-520-69. These tablets are only available by prescription and are manufactured by SUN PHARMA. Each package contains 9 tablets that are for unit-of-use only. These tablets are intended to be swallowed whole with water and are not to be spit out or removed from the blister pack until immediately prior to use. The recommended dosage information can be found on the package insert. The tablets should be stored at 20° to 25°C and should never be stored in any container other than the blister pack. To use, tear the blister packaging and remove the tablet with dry hands.*

This is a description of medication in tablet form called Sumatriptan Succinate. Each unit contains 9 tablets, and each tablet has 50mg of sumatriptan succinate. The tablets are manufactured by Sun Pharma and should be swallowed whole with water. They should not be chewed or removed from their blister pack before immediate use. Further information on dosage can be found on the package insert. The medication should be stored between room temperature and 25°C or 77°F. This description also includes a National Drug Code (NDC) number.*

The figure shows the probability of obtaining initial headache response within 4 hours of treatment with oral sumatriptan. The plot is based on pooled data from three clinical controlled trials and displays the estimated probability of a response based on the sumatriptan dosage. The probability of response was observed to increase with the sumatriptan dose from 25mg to 100mg. The plot indicates that the highest probability of response was achieved within 120 minutes of the initial dose. The data is displayed in a Kaplan-Meier plot, and patients who did not achieve a response or took rescue medication within 240 minutes were censored.*

This is a figure showing the estimated probability of patients taking a second dose of a medication (Sumatriptan Succinate or placebo) to treat migraine over 24 hours following the initial dose in three controlled trials. The Kaplan-Meier plot is based on data from patients who did not use additional treatments and were censored to the 24-hour timeframe. Patients who did not respond to the initial dose were also included, but no remedication was allowed within two hours post dose.*

Each tablet contains sumatriptan succinate, USP equivalent to 100 mg of sumatriptan. The usual dosage information is provided in the package insert. Swallow tablets whole with water and do not split the tablets. It is recommended to store this drug between 20° to 25°C (68°to 77°F), with excursions permitted to 15° to 30°C (59° o 86°F). This drug is available only by prescription. The patient information leaflet should be dispensed with this drug product. This drug is distributed by Sun Pharmaceutical Industries, Inc. and manufactured in Gujarat, India.*

Each tablet contains 25 mg of sumatriptan succinate and is intended for oral use by adults. They should be swallowed whole with water and should not be crushed or chewed. Sumatriptan is used to treat migraines and works by narrowing blood vessels in the brain, thereby reducing the pain caused by migraines. The usual dosage instructions can be found in the package insert. The tablets should be stored at room temperature (20-25°C/66-77°F) and kept away from light and moisture. A pharmacist should dispense the medication and provide the patient with an information leaflet.*

Each tablet of this medication contains sumatriptan, an active ingredient used to treat migraine headaches. The tablets are manufactured by Sun Pharmaceutical Industries and contain 50mg of sumatriptan succinate, USP equivalent. It is important to swallow the tablets whole with water and not to chew them. The recommended dosage can be found in the package insert provided. This medication should be stored at room temperature and kept away from excursions that can cause the temperature to rise or fall. This information is valid as of December 2014.*